Additional Proxy Soliciting Materials (definitive) (defa14a)
June 11 2021 - 4:06PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No. )
Filed by the Registrant x
Filed by a Party other than the Registrant ¨
Check the appropriate box:
|
¨
|
Preliminary Proxy Statement
|
|
¨
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
¨
|
Definitive Proxy Statement
|
|
x
|
Definitive Additional Materials
|
|
¨
|
Soliciting Material under §240.14a-l2
|
Zynerba Pharmaceuticals, Inc.
|
(Name of Registrant as Specified In Its Charter)
|
|
|
(Name of Person(s) Filing Proxy Statement,
if other than the Registrant)
|
|
Payment of Filing Fee (Check the appropriate box):
|
¨
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
|
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
|
|
|
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined):
|
|
|
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
|
|
|
¨
|
Fee paid previously with preliminary materials.
|
|
¨
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting
fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
(1)
|
Amount Previously Paid:
|
|
|
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
|
|
|
|
(3)
|
Filing Party:
|
|
|
|
|
(4)
|
Date Filed:
|
|
|
|
YOUR IMMEDIATE ATTENTION IS
REQUESTED
Annual Meeting of
Stockholders Adjourned
WE
NEED YOUR PARTICIPATION
Dear Stockholder:
We have been trying to reach you
in connection with the Annual Meeting of Stockholders of Zynerba Pharmaceuticals, Inc. (the “Annual Meeting”), which was originally
scheduled to be held at 10:00 a.m. EDT on June 9, 2021 but has been adjourned until 9:00 a.m. EDT on June 29, 2021 due to lack of quorum.
In order to conduct the business of the Annual Meeting, including electing the Board of Directors of the Company, we are required to reach
a quorum for the meeting.
We still have not yet received
your vote. You may think your vote is inconsequential, but your participation helps us to avoid costly additional adjournments and solicitations.
We are asking you to please take a moment now to submit your vote.
The proxy statement is available online at www.astproxyportal.com/ast/20275.
In order for your vote to be represented, we must receive your voting instructions. For your convenience,
please use any of the following methods to submit your vote:
Follow the simple instructions on your proxy card or at
the link accompanying this notice.
Call the toll-free number located on your proxy card and
follow the simple instructions.
Sign, Date, and Return your proxy card through the mail.
If possible, please use either of the first two options
to ensure your vote is captured in time for the meeting. Even if it is past the indicated deadline, please submit your vote!
If you have any questions, please call Okapi Partners,
our proxy solicitor, toll-free at 1-844-343-2621. Representatives are available Monday - Friday 9:00 a.m. to 9:00 p.m. (EDT) and Saturday,
10:00 a.m. to 5:00 p.m. (EDT).
Please take a moment and vote today!
Thank you!
Zynerba Pharmaceuticals (NASDAQ:ZYNE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Zynerba Pharmaceuticals (NASDAQ:ZYNE)
Historical Stock Chart
From Sep 2023 to Sep 2024